Dawn P. Eringis
Corporate Officer/Principal at PolyMedix Pharmaceuticals, Inc.
Profile
Dawn P.
Eringis has been Director of Business Development for PolyMedix, Inc. and Vice President of PolyMedix Pharmaceuticals, Inc. since January 2003.
Ms. Eringis had been Vice President of Business Development for PolyMedix, Inc. since November 2005.
She has more than 18 years of biopharmaceutical industry experience.
Previously, Ms. Eringis was Director of Business Development for Locus Discovery from 2000 to 2002 and held a variety of business development positions at Guilford Pharmaceuticals from 1997 to 2000.
Prior to 1997, she held various chemical engineering and marketing positions with Johnson & Johnson, Proctor and Gamble, Pfizer and Rohm and Haas Company.
Ms. Eringis received a BS degree in Chemical Engineering from the University of Pennsylvania and an MBA from The Wharton School at the University of Pennsylvania.
Dawn P. Eringis active positions
| Companies | Position | Start |
|---|---|---|
| PolyMedix Pharmaceuticals, Inc. | Corporate Officer/Principal | 01/01/2003 |
Former positions of Dawn P. Eringis
| Companies | Position | End |
|---|---|---|
Locus Pharmaceuticals, Inc.
 Locus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Locus Pharmaceuticals is a pharmaceutical company focused on developing novel, small molecule therapeutics to address major unmet medical needs. Locus utilizes powerful and proprietary computational technologies running on Linux-based supercomputer clusters to simultaneously identify relevant binding sites on protein disease targets and rapidly generate novel, small molecules that bind specifically to those protein sites. In contrast to other computational approaches, the Locus technology requires only a high-resolution, 3-dimensional structure of the target protein to implement its drug discovery process. Locus Pharmaceuticals is synthesizing and testing novel drug candidates for the treatment of debilitating and life-threatening human diseases, including HIV/AIDS, cancer, arthritis and inflammation. | Corporate Officer/Principal | 01/01/2002 |
| POLYMEDIX, INC. | Corporate Officer/Principal | - |
Training of Dawn P. Eringis
| University of Pennsylvania | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
PolyMedix, Inc.
 PolyMedix, Inc. Pharmaceuticals: MajorHealth Technology PolyMedix, Inc. engaged in developing first-in-class, small-molecule defensin-mimetics for the treatment of serious acute care conditions. The company was founded in 2002 and was headquartered in Radnor, PA. | Health Technology |
| PolyMedix Pharmaceuticals, Inc. | |
Locus Pharmaceuticals, Inc.
Locus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Locus Pharmaceuticals is a pharmaceutical company focused on developing novel, small molecule therapeutics to address major unmet medical needs. Locus utilizes powerful and proprietary computational technologies running on Linux-based supercomputer clusters to simultaneously identify relevant binding sites on protein disease targets and rapidly generate novel, small molecules that bind specifically to those protein sites. In contrast to other computational approaches, the Locus technology requires only a high-resolution, 3-dimensional structure of the target protein to implement its drug discovery process. Locus Pharmaceuticals is synthesizing and testing novel drug candidates for the treatment of debilitating and life-threatening human diseases, including HIV/AIDS, cancer, arthritis and inflammation. | Health Technology |
- Stock Market
- Insiders
- Dawn P. Eringis
